|
NCI Special Notes
This is an NCI-specific program announcement. For all of the policies governing this award mechanism, refer to the Program Announcement: PAR-06-449 PAUL CALABRESI AWARD FOR CLINICAL ONCOLOGY (K12).
Summary Information on Program (We have created suggested tabular formats for your convenience. "Click on" TABLES (Word for Windows) or TABLES (Adobe for Acrobat Files), which ever you prefer to download this information.
The National Cancer Institute (NCI) Paul Calabresi Career Development Award for Clinical Oncology (K12) must be in compliance with all NIH/NCI policies pertaining to the use of human subjects. These policies apply to all research involving human subjects, not just clinical trials. The K12 is a training and career development grant in which candidate positions are filled at the discretion of the institution and assignment of candidate positions is generally not known at the time of application or at the time of an award. Due to this uncertainty, the word "Indefinite" should be placed in the box for IRB review date on the face page of the application and the applicant institution must provide in the submitted grant application a Special Statement on Human Subjects Research.
The complete Special Institutional Statement Regarding Human Subjects Research Under K12 Support may be accessed by clicking
K12 Special Institutional Statement Regarding Human Subjects Research.
Inquiries are encouraged, and the opportunity to clarify any issues or questions is welcome. Inquiries should be sent to:
Dr. Dorkina Myrick
Cancer Training Branch
National Cancer Institute
6116 Executive Boulevard, Suite 7019
Rockville, MD 20852 (overnight mail)
Bethesda, MD 20892-8346 (regular mail)
Telephone: (301) 496-8580
FAX: (301) 402-4472
Email: myrickd@mail.nih.gov
< Previous Section | Next Section > |
